Pharsight Monthly Summary
November, 2026
Recent happenings in patent protected drugs.
spacer_11
At a Glance
125
drug patents lapsed
Photos
81
new drug patents introduced
Reviews
What's New on Pharsight?

Patent Challenge Updates

Discover for which innovator drugs Paragraph IV certifications have been filed, signaling opportunities to launch generics before patent expiry. Find this section right under Generic Launch on any drug page to stay ahead of the market and identify actionable opportunities.

Recent & Tentative Approvals

Track the latest innovator and generic drug approvals along with tentative approvals and submission timelines to identify drugs moving closer to market entry. This helps uncover pipeline momentum, anticipate upcoming launches, and better understand how a company’s portfolio is evolving. Simply search for any company on Pharsight and find this in the Recent Approvals & Tentative Approvals section of the company page.

spacer_11
spacer_11
spacer_11

High Competition Drugs Alert
See which drugs have the most crowded generic market and intense competition right now.
Drug (ANDA Filed) Primary Patent Status Market Size
Eliquis 25 Expiring Soon $13.3B
Latuda 14 Expired -
Bridion 14 Expired $1.8B
Tradjenta 11 Expired -
Opsumit 11 Expired $2.3B
Kyprolis 9 Expired -
Jentadueto 8 Expired -

Drug patents lapsed
Spot drugs with expired patents that present new generic development opportunities.
Drug Patent Patent expiry
Adasuve 8387612 23 Oct, 2026
Androgel 8446138 12 Oct, 2026
Androgel 8466136 12 Oct, 2026
Androgel 8466137 12 Oct, 2026
Androgel 8466138 12 Oct, 2026
Androgel 8486925 12 Oct, 2026
Androgel 8729057 12 Oct, 2026
See more

Newly introduced Drug Patents
Discover the latest drugs receiving patent protection, signaling innovation and new market entrants
Drug Patent Patent expiry
Akeega 12734180 30 Sep, 2043
Aqneursa 12144792 19 Apr, 2037
Beizray 11419842 16 May, 2036
Beizray 12090134 16 May, 2036
Beizray 12090135 16 May, 2036
Bixlenvo 10071985 17 Aug, 2037
Bixlenvo 10385067 19 Jun, 2035
See more

Recent patent litigations
Stay updated on recent drug patent lawsuits shaping the competitive landscape.
Patent Petitioner Proceeding Date
US12280146 Sun Pharmaceutical Industries, Inc. 16 Jan, 2026
US12233106 Ascendis Pharma A/s 24 Nov, 2025
US11344552 Apotex Inc. 12 Sep, 2025
US9474780 Bpi Labs, Llc 04 Aug, 2025
US8268847 United Therapeutics Corporation 10 Jun, 2025
US9474780 Empower Clinic Services, Llc. (D/b/a Empower Pharmacy) 22 May, 2025
US8623826 Azurity Pharmaceuticals, Inc. 01 May, 2025
See in detail
spacer_11
Companies with Newly Granted Drug Substance Patents
Company Ingredient
Alnylam Pharms Inc Lumasiran Sodium
Astrazeneca Camizestrant
Bristol Myers Squibb Iberdomide Hydrochloride
Genzyme Corp Fitusiran Sodium
Gilead Sciences Inc Bictegravir Sodium; Lenacapavir Sodium
Gilead Sciences Inc Bictegravir Sodium, Lenacapavir Sodium; Lenacapavir Sodium
Haisco Cipepofol
Ionis Pharms Inc Zilganersen Sodium
Priovant Therap Brepocitinib Tosylate
Revolution Medicines Daraxonrasib
Takeda Pharms Am Rusfertide Acetate
spacer_11
View past newsletters
January, 2026
December, 2025
November, 2025

Our insights are consumed by 1000+ leading pharma companies

© 2026 GreyB Research